CTRB2
| Official symbol: | CTRB2 |
| Full name: | chymotrypsinogen B2 |
| Location: | 16q23.1 |
| Also known as: | |
| Entrez ID: | 440387 |
| Ensembl ID: | ENSG00000168928 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | NA |
|
|
|
| |
|
|
|
| Functional class: | Enzyme |
| JensenLab PubMed score: | 0.24 (Percentile rank: 4.30%) |
| PubTator score: | 8.03 (Percentile rank: 36.15%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | N/A |
| Tractability (antibody): | Predicted Tractable - High confidenceTargets located in the plasma membrane; Targets with GO cell component terms plasma membrane or secreted |
